RESEARCH-USE BIOSIMILAR ANTIBODY
Atezolizumab
Monoclonal antibody · IgG1
Atezolizumab (MPDL3280A) is a selective humanized monoclonal IgG1 antibody against programmed death ligand 1 (PD-L1), used for cancer research.
TARGETPDL1
YMonoclonal antibody
CATALOGSC-BS-760
CATALOG NUMBERSC-BS-760
MOLECULAR WEIGHTApprox. 144.6 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Atezolizumab (MPDL3280A) is a selective humanized monoclonal IgG1 antibody against programmed death ligand 1 (PD-L1), used for cancer research.
Atezolizumab is a recombinant research-use antibody directed against PDL1.